Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Latest press releases
- FDA approves Nucala (mepolizumab) 40 mg prefilled syringe for children with severe eosinophilic asthma
- Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows
- Tony Wood appointed Chief Scientific Officer designate, GSK
- Update - GSK Consumer Healthcare
GSK US Twitter
-
GSKUS @GSKUS
Severe asthma can have an impact on a patient’s quality of life, as their asthma symptoms can remain uncontrolled despite high-dose standard treatments. Learn more about our new administration option: gsk.to/3H555R8
about 1 day ago -
GSKUS @GSKUS
A follow-up claims analysis commissioned by GSK & conducted by @avalerehealth showed routine vaccination rates for teens & adults continue to lag behind pre-pandemic levels. It's important we raise awareness of routine vaccines for public safety. Details: gsk.to/32rHV8g
about 2 days ago
-
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Consumer Healthcare develops brands in Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
